Romiplostim 250microgram powder and solvent for solution for injection vials
NHS hospitals in England used £36,772,093 of indicative cost of Romiplostim 250microgram powder and solvent for solution for injection vials in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 469.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Romiplostim 250microgram powder and solvent for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Romiplostim 250microgram powder and solvent for solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| South Tyneside And Sunderland Nhs Ft | £1,468,654 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,395,872 |
| Manchester University Nhs Ft | £981,159 |
| University College London Foundation Tr | £978,460 |
| Barts Health Nhs Trust | £948,576 |
| University Hospitals Dorset Nhs Ft | £747,582 |
| Royal Devon & Exeter Nhs Foundation Trst | £711,914 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £693,598 |
| Leeds Teaching Hpls Nhs Trust | £687,814 |
| Imperial College Healthcare Nhs Trust | £684,440 |
The primary-care picture
Romiplostim is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Romiplostim medicine page.